November 18, 2026
Health news, explained with evidence
LIVE
Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine

Empirical Tuberculosis Treatment Shows No Mortality Benefit in Infants With HIV and Severe Pneumonia

❤️ Conditions & Care 1 min read 👁 17

A multicenter clinical trial published in The Lancet found that empirical tuberculosis treatment did not reduce all-cause mortality compared to a guided strategy in infants with HIV-associated pneumonia.

❤️Conditions & Care

Key points

  • The multicenter trial evaluated empirical tuberculosis treatment for infants with HIV and severe pneumonia.
  • Results published in The Lancet showed no reduction in all-cause mortality compared to guided strategies.
  • High rates of delayed tuberculosis treatment initiation in the comparison group may have affected trial outcomes.

A recent multicenter clinical trial evaluated whether empirical tuberculosis treatment (eTB-T) could lower mortality rates among infants living with HIV who were hospitalized with severe pneumonia in Africa. Conducted as a randomized, open-label, controlled superiority study, the research compared empirical treatment strategies against clinically and microbiologically guided approaches. According to the findings published in The Lancet, the empirical approach showed no evidence of superiority in reducing all-cause mortality for this vulnerable patient group.

Study authors noted that a significant number of infants in the comparison groups ultimately initiated tuberculosis treatment during the follow-up period. This high rate of delayed treatment initiation may have minimized the differences between the study arms, potentially limiting the trial's capacity to detect contrasting outcomes between the two medical strategies.

Because the trial focused on a specific high-risk demographic, experts emphasize that findings should be interpreted within the context of hospital settings in Africa. Observational and trial limitations, including overlapping treatment trajectories, suggest that further investigation is needed to optimize care pathways for infants managing both HIV and severe respiratory infections. Patients and caregivers should consult qualified healthcare professionals regarding individual medical decisions.

Source The Lancet — thelancet.com/journals/lancet/article/PIIS0140-6736(26)01418-2/full… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.